Please select the option that best describes you:
Topics:
Gastroenterology • Obesity Medicine
How would you manage a patient taking a GLP-1 agonist for weight loss who continues to have symptoms (i.e., nausea, vomiting) related to reduced GI motility despite dose adjustments?
Would you anticipate a different side effect profile from a different GLP-1 agonist?